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ACROLEIN-INDUCED EPIGENETIC MODIFICATION OF DNA METHYLATION
IN RAT KIDNEY TISSUE
By
Uchechi Grace Nwaiwu, PhD.
Texas Southern University, 2021
Professor Zivar Yousefipour, Advisor

Acrolein, an alpha-beta unsaturated aldehyde, and a very reactive and toxic compound is released
into the environment from different sources. As a pervasive environmental pollutant, acrolein
poses a serious environmental health threat acknowledged by investigators, health, and
environmental government agencies. Acrolein is released into the environment through the
burning of organic compounds. The main sources of acrolein pertinent to human health and
toxicity include cooked foods, combustion of fossil fuels, cigarette smoke, overheating of frying
oil, endogenously produced via lipid peroxidation, metabolism of polyamine, and anticancer drug
cyclophosphamide. Exposure of humans to acrolein is mainly through inhalation of contaminated
air, ingestion of contaminated food, and water and dermal contact. Exposure and buildup of
acrolein in the biological system have been linked to different disease conditions such as cancer,
cardiovascular diseases, multiple sclerosis, spinal cord injury, and Alzheimer’s diseases.
Several mechanisms have been proposed for the toxicity of acrolein including inflammation,
protein abduction, oxidative stress, DNA abduction, and membrane disruption. Some studies have
linked acrolein-induced toxicity to epigenetic modifications. Epigenetics is the modifications in
gene expression that do not alter the DNA sequence of a gene. This alteration could occur
naturally or by factors such as age, environmental exposure, individual lifestyle, and disease
condition. DNA methylation is an epigenetic process that ensues via the addition of a methyl
(CH3) group to DNA and frequently alter the role of the gene and transcription factor and as such
influence gene manifestation. DNA methyltransferases ( DNMTs) are a group of enzymes that
control the addition of methyl groups at different levels in the cells. There are three major types
of DNMTs; DNMT1 is the methylation enzyme responsible for the maintenance of established
patterns of DNA methylation while DNMT3A and DNMT3B mediate the establishment of new
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or de novo DNA methylation patterns. On the other hand, Ten Eleven Translocation (TET)
enzymes counter the activities of DNA methyltransferases via stepwise biochemical conversion
of 5- methylcytosine to 5-carboxyl cytosine, which is then modified by thymine DNA glycosylase
(TDG) making it a basic cytosine which allows the regeneration of unmethylated cytosine
through base excision repair thereby abolishing DNA methylation.
N- Acetylcysteine (NAC) is an antioxidant that is vital for the reduction of oxidative stress and
the downstream negative effects that are associated with it. NAC has shown potency in the
inhibition of acrolein-induced toxicity based on the recent studies done in our laboratory and
other investigators. NAC beneficial effects are through improvement in the production of cellular
glutathione, a natural antioxidant enzyme known to defend the body against the invasion of
xenobiotics such as acrolein. Our earlier work using Vascular Smooth Muscle Cells (VSMCs) has
indicated that acrolein induces cytotoxicity and modifies histones specifically histone H3, through
epigenetic modification via methylation and acetylation and NAC blocks the toxicity and inhibits
histone modification. Based on current information, we are hypothesizing that acrolein toxicity is
through changes in DNA methylation and NAC prevents this toxicity by inhibiting DNA
methylation. Specific aims of the study are: To demonstrate that acrolein induces toxicity in rats
is through DNA methylation, Evaluate the activities of DNA methylation/demethylation
enzymes, Evaluate the effect of N-acetylcysteine (NAC) on the prevention of DNA methylation
and subsequent changes. To investigate our hypothesis, male Sprague-Dawley rats were treated
with 2mg/kg/day of acrolein for seven days (i.p) in the presence or absence of 600mg/kg/day of
NAC (i.p). The dose and duration of exposure were selected based on our previous studies. At the
end of the study period, kidney tissue was collected, nuclear protein and DNA samples were
extracted for biochemical analysis. Lipid peroxidation was measured using MDA
(Malondialdehyde)-based colorimetric assay. 5-mC hydroxylase TET activity, DNMT activity,
Thymine DNA glycosylase activity, DNA Demethylase activity, and DNA Damage
Quantification (8-OHdG) were measured by ELISA-based colorimetric and fluorometric assay
from Epigentek. Global DNA methylation and global DNA hydroxymethylation were measured
by ELISA-based colorimetric assay from Abcam and protein expression by western blotting. Our
results revealed that acrolein-treated rats showed about a 169% increase in lipid peroxide level
when compared to the control group. The addition of NAC decreases lipid peroxidation level to
about 52% compared to the acrolein group. There was about a 67% decrease in 5-mC TET
Hydroxylase activity in the acrolein treated group compared to the control group, the addition of
NAC increased 5-mC TET Hydroxylase activity by 28% compared to the acrolein group.
Consistently, there was about a 14% decrease in demethylase activity in the acrolein group
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compared to the control group and the addition of NAC increased demethylase activity to about
20% compared to the acrolein group. Similarly, there was about a 22% decrease in TDG activity
in the acrolein treated group compared to the control and the addition of NAC showed an
approximately 15% increase in TDG activity compared to the acrolein group. On the contrary,
there was about a 30% increase in DNMT activity in the acrolein group compared to the control.
The addition of NAC indicated about 32% increase compared to the acrolein group. The reason
behind the increase in DNMT activity after the addition of NAC is yet to be understood since
NAC is known to repeal acrolein toxicity. There was up to 16% increase in the global 5-mC level
in the acrolein treated group compared to the control and the addition of NAC increased it by
16% when compared to the control. The same trend was observed in global 5-HmC where there
was a 22% decrease in 5-HmC activity in the acrolein group compared to the control. The
addition of NAC increased the level of 5-HmC approximately to 130% compared to the acrolein
group. The decrease in global 5-mC and 5-HmC agrees with many investigators’ reports
(hypomethylation) as the prognosis of different cancer development. Finally, there was about an
18% decrease in the 8-OHdG level in the acrolein group compared to the control and NAC
addition increased the 8-OHdG level by 167% compared to the acrolein group. Based on the
present data, we are concluding that epigenetic changes observed in acrolein-treated rats are the
results of increased generation of ROS, which contribute to increasing oxidation level, alteration
of TET enzymes and their products, as well as an increased in DNA methylation and subsequent
DNA damage.

CHAPTER 1
INTRODUCTION
1.1 Acrolein
Acrolein, also known as 2-propenal, is an unsaturated aldehyde with a chemical formula
of CH2CHCHO. The compound is a yellow or colorless liquid with unpleasant odor
which is reported to be an environmental pollutant due to its widely used in industry.
Acrolein is a prevalent noxious compound which is easily distributed into the
environment from several sources. Its ubiquitous presence in our surrounding, presents
health hazard to all livings including human and animal. Environmental Protection
Agency (EPA) has listed acrolein as a priority toxic compound to the environment (EPA,
2007). According to World Health Organization, the estimated tolerable daily intake
(TDI) of acrolein is 7.5mg/kg of body weight (World Health Organization Geneva,
2002).
The Agency for Toxic Substance and Disease Registry (ATSDR) has reported that
acrolein minimal acute level centered on respiratory effects on human is 0.007 mg/cm3 or
0.003ppm (ATSDR. 2003).
1.2 Sources of Acrolein
Numerous sources of acrolein is the reason of its widespread in the environment. The
exogenous sources of acrolein includes automobile exhaust, forest fires, cigarette smoke,
industrial waste. Acrolein is produced in the body through metabolism of polyamines,
threonine, and anticancer drug cyclophosphamide (Francis et al., 2013). Acrolein can also
1
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be produced endogenously through the conversion of hydroxy-amino acid (threonine) to
acrolein in the present of hydrogen peroxide and chlorine ion. Furthermore, acrolein is
produced by copper-dependent amine oxidation of spermidine and spermine via the
impulsive retro-Michael addition cleavage (Steven & Maier, 2008). Fried food, alcoholic
beverages, charred meat and prolong heating of vegetable oil are the dietary sources of
acrolein.
1.3 Metabolism of Acrolein
Assimilation of acrolein into the body system is due to its high solubility nature. Acrolein
combines with important cellular antioxidants examples as thioredoxin and glutathione
and forms conjugates. Glutathione S-transferase catalyzes conjugation of glutathione by
acrolein. The resultant product of acrolein combination with glutathione can be broken
down by different enzyme reaction to form different harmful products. For instance,
acrolein conjugate with glutathione forms 2-carboxyethyl mercapturic acid (CEMA) via
aldehyde dehydrogenase breakdown, forming a known urinary byproduct S-(3hydroxypropyl)- mercapturic acid (3-HPMA) by Aldo-keto reductase (Mohammad et al.,
2015). In addition, metabolites of acrolein can further undergo oxidation and epoxidation
reaction with conjugates of glutathione to yield a carcinogenic compound,
glyceraldehyde, recognized to be deleterious to human health (Smita et al., 2015). The
byproduct of acrolein interaction with biological nucleophiles has been linked to harmful
effect of acrolein to human and animals (Stevens & Maier, 2015).
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1.4 Uses of Acrolein.
The high industrial demand for acrolein has increased the production of acrolein to over
500, 000 tons per year (Nauman et al., 2014; Journal of Catalysis 2016). The different
uses of acrolein include as a micro biocide in an oil well, as a slimicide in paper
manufacturing, and as a warning agent in methyl chloride refrigerant. Acrolein is used in
the production of poisonous gas mixtures for military purposes, as a coolant in water
towers, in the manufacture of plastics and perfumes, production of pesticides , acrylic
acid, as an algaecide and herbicide in irrigation canals, used to produce colloidal forms of
metals, and as a liquid hydrocarbon fuel.
1.5 Exposure and Health Impacts of Acrolein
U.S Environmental protection Agency has cataloged acrolein toxicity as a main concern
to environmental health. In united states, acrolein has been known to present a health
risk, and discovered to be in a substantial amount in many schools and homes (Logue et
al., 2012). Exposure of human to acrolein could be via airborne, occupational, and dietary
exposure. The common routes of exposure include inhalation, ingestion and contact with
the skin. Prolonged cigarette and hookah smokers, as well as people living in densely
polluted environment and firefighter are more predisposed to acrolein exposure (Daffa et
al., 2014). Contact of acrolein with different organs of the body such as the skin, eye,
lung, kidney, and liver, has been reported to cause various harmful effects such as
redness, irritation, inflammation, congestion etc. Also, elevated acrolein adducts have
been reported to be the underlying pathology of numerous ailments linked to oxidative
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stress such as Sjogren’s syndrome, autoimmune disorder, cerebral stroke, and infarction
(R. Saiki et al., 2011). Uncleared acrolein conjugate with glutathione could result in
covalent protein adducts, causing compromised protein structure and function. Buildup of
such adduct and or misfolded proteins can induce ER stress, and acrolein-induced ER
stress is shown in vitro in various cell types (Jingwen et al., 2016).
High level of 3-HPMA (acrolein byproduct) in urine has been seen in stroke patient and
decreased level of 3-HPMA has been reported to reduce the development of stroke
(Mikamia et al., 2012). Research has shown that reduced level of glutathione in the
nervous system is due to the formation of GSH-acrolein conjugate which results in the
aggravation of stroke (Takahiro et al., 2012). In addition, several chronic disease
conditions such as various types of cancer, Alzheimer’s, and cardiovascular disease,
neurological, nephrological and hepatological toxicity, spinal cord injury, multiple
sclerosis, and diabetes mellitus has been connected to acrolein by multiple reports from
investigators (Akshata et al., 2015).
A study by Katia et al., (2014) reported detection of the exact damaging agents in
cigarette smoke (CS) responsible for reduced Salivary lactate dehydrogenase (LDH)
enzyme activity and mechanisms involved in CS oxidative damage. Purified LDH
samples was subjected to separate levels of CS, acrolein. acetaldehyde, peroxynitrite and
RNS donors. Response of these various exposures was assessed by spectrophotometric
enzyme activity assay and western blot analysis. The result showed that CS exposure
resulted in 34% in LDH activity, exposure to 10 µmol of acrolein caused 61% reduction,
while acetaldehyde, peroxynitrite and RNS donors exposure resulted in no significant
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effect. The carbonyl immunoblotting assay showed a fourfold increase in carbonyl
content when treated with CS and a sevenfold increase when treated with acrolein, which
revealed that acrolein, an alpha-beta-unsaturated aldehyde, was the major component of
CS responsible for reduced salivary LDH activity.
Previous work in our laboratory, using rat models treated with 2 and 4 mg acrolein/kg
body weights, reported elevated blood pressure due to a reduction in nitric oxide
availability, a rise in lipid peroxidation, and a decrease in Cyclic guanosine
monophosphate (cGMP). The authors concluded that the increase in blood pressure was a
result of changes in the level of GST and GST-Px detoxifying enzymes that inflated
vascular response to phenylephrine (Yousefipour et al., 2005).
In another study, Wei Yang Chen et al., (2016) examined the pathogenic role of acrolein
in hepatic endoplasmic reticulum (ER) stress, steatosis, and injury in experimental
Alcohol Liver Disease (ALD). In vitro hepatoma H4IIEC cells and in vivo chronic plus
binge alcohol feeding in C57Bl/6 mice models were used to examine alcohol-induced
acrolein accumulation and consequent hepatic ER stress, apoptosis, and injury were
examined both in vitro and in vivo. The result showed alcohol intake and metabolism
resulted in hepatic accumulation of acrolein-protein adducts, by up-regulation
of cytochrome P4502E1 and alcohol dehydrogenase, and down-regulation of glutathiones-transferase-P, known to breakdown or detoxifies acrolein. In addition, alcohol-induced
acrolein adduct accumulation led to hepatic ER stress, proapoptotic signaling, steatosis,
apoptosis, and liver injury. Damage to DNA as well as DNA repair proteins leading to
abnormal repair and increases in cells and mutational vulnerability has been reported to
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have connection with acrolein interaction. Although, these effects might amount to
acrolein lung carcinogenicity, the machineries by which acrolein induces lung diseases
excluding cancer are undefined. (Hsiang-Tsui Wang et al., 2017).
A previous study done in our laboratory using Vascular smooth muscle cells has shown
that acrolein causes cytotoxicity through epigenetic modification of H3 histones via
epigenetic modification mechanism (methylation and acetylation) and as such alters gene
expression (unpublished data).
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CHAPTER 2
LITERARY REVIEW
2.1 Acrolein Mechanism of Toxicity
A strong electrophile, acrolein possess high affinity to bind and react with endogenous
nucleophiles such as proteins, DNA, glutathione etc. The interaction of acrolein with
cellular molecules are the major pathways for acrolein toxicity. This can occur due to
reaction with proteins resulting in protein abduction and binding to DNA leading to
abnormal DNA abduction. Studies have reported different mechanisms that acrolein exert
toxicity. Such mechanisms includes oxidative stress, inflammation, endoplasmic
reticulum stress and mitochondrial stress (Akshata et al., 2015). Acrolein causes damage
to the body by weakening the body immune system via the inhibition of immune system
(suppression of NF-kB protein complex) from countering the invasion of virus and
bacteria attack as well as harmful pollutants.
2.2 Acrolein Causes Inflammation
Inflammation is a process of body immune response against harmful attacks such as
injuries, infection, and toxins with the purpose to repair or heal. Prolonged inflammation
occurs when the immune response persist exposing the body in a steady state of
awareness. The healing response requires the release of important endogenous molecules
such as proteins, antibodies, and elevated blood flow. It has been echoed in many
investigations that one of the common acrolein mechanism of toxicity is the induction of
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inflammation through enhancing the generation of ROS and acting as a free radical.
Acrolein has been reported to provoke pulmonary inflammation as well as lung epithelial
cells death through the generation of NF-κB signaling in a mouse in vivo study (Sun Y et
al., 2014). Acrolein also triggers NF-kB pathway and stimulate pro-inflammatory
cytokines including cyclooxygenase-2 (Sarkar et al., 2007). Furthermore, acrolein
induces TNF-α, IL-6, and IL-8 mRNA expression via NF-κB stimulation in human
umbilical vein endothelial cells (HUVECs) (Haberzett et al., 2004). A research was done
to expose acrolein proinflammatory ability in primary nasal epithelial cell (PNECs) along
with nicotine and acetyl aldehyde. PNECs from 19 healthy subjects were grown in
submerged cultures and incubated with acrolein, nicotine, and CSE preceding to
stimulation with Pseudomonas aeruginosa lipopolysaccharide (PA LPS). The data
showed that four-hour exposure of 30 µM of acrolein to PNECs resulted in two-fold
increase in IL-8 (pro-inflammatory) and increase release of IL-8 after stimulation with
PA LPS compared to nicotine anti-inflammatory 0.6-fold release of IL-8 after 50μM
exposure to nicotine for 24 h, which exposes acrolein pro-inflammatory ability in PNEC
cultures (David M. et al., 2014).
2.3 Protein Abduction by Acrolein
High Reactivity of acrolein with important biological molecule such as protein leads to
abnormal protein function. For instance, acrolein reacts with protein residues such as
cysteine, lysine, and histidine of the peptide chain through Michael-type addition. The
resultant lysine abduct, N-(3-formyl-3, 4-dehydropiperidino) FDP-Lys is an unstable
intermediate that covalently attached to thiols for example, glutathione via
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reserved electrophilic carbonyl moiety (Aldini et al., 2011). The interaction of FDP-Lys,
glutathione and acrolein is found to diminish cellular glutathione, an important
antioxidant principally known to combat acrolein assault, thus, increasing the level of
oxidative stress and as such impinge body defense mechanism (Luo & Shi, 2005).
Acrolein has be found to play an vital part in the emergence of systemic maladies,
examples are neurodegenerative diseases (Wood et al., 2007), cardiovascular diseases
(DeJarnett et al., 2014), and diabetes (Daimon et al., 2003).
A study reported that acrolein FD-Lys abduct was found in high concentration in the
vitreous fluid of patients with Proliferative Diabetic Retinopathy (PDR). High level FDLys was also seen in glial and endothelial cells of the fibrovascular tissues obtained from
patients with PDR indicating acrolein play a part in the pathogenesis of diabetes
retinopathy (Miyuki et al., 2020).
2.4 DNA Abduction by Acrolein
Reactive oxygen species generation by acrolein via reaction with DNA which could lead
to gene mutation as well as carcinogenicity. Another way acrolein induce toxicity is
through reaction with deoxy guanosine (dG) producing two cyclic DNA adducts, a- and
c-hydroxy-1, N2-propano-20-deoxyguanosine leading to mutagenicity at a different level
in cell. Formation of DNA adducts with acrolein have been described in vitro and have
also been identified in vivo in several different animal, human tissues, and cells (Franco
et al., 2011). Acrolein is also known to provoke DNA damage as well as inhibit the repair
by impeding repair enzymes possibly by acrolein-adduction resulting in an enhanced
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proteasome-dependent deprivation (Wang et al., 2012). CpG sites are known to be
susceptible to acrolein-DNA adduction, elevated acrolein-induced G-to-T and G-to-A
mutation occurrence to levels found in the CpG sites in the p53 gene, is recognized to be
mutational hot spot in tobacco smoke-associated lung cancer (Wang et al., 2013).

Figure 2.1: Schematic Representation of Acrolein Effects on DNA (S.Joshi-Barve,
2016).
2.5 Oxidative Stress
Oxidative stress is the generation of free radicals and the inability of body antioxidants to
inhibit the harmful effects of these reactive oxygen species (ROS). ROS is known to be
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reason behind different physiological functions such as cell signaling and are usually
produced as a byproduct of oxygen metabolism as well as environmental pollutants.
Acrolein reaction with cellular lipid leads to production of free radicals which contributes
to increased oxidative stress. It has been reported that acrolein reduction of endogenous
glutathione results in the elevated oxidative stress and cell death in retinal microvascular
endothelial cells and glial cells (Murata et al., 2017 & 2019). In addition, spermine
oxidation by VAP-1 or SMOX leads to acrolein generation and aggravation of oxidative
stress in the micro-environment either by restricting the antioxidant defense system or
increasing generation of reactive oxygen species ( Wu D et al., 2020).
An investigation was carried out by (Masanori et al., 2019) to examine the pathological
effects acrolein of in COPD development. Acrolein concentration was assessed in plasma
from 47 patients with COPD and 18 current smokers without COPD, and in supernatants
of homogenized lung tissues obtained from 10 never-smokers, 8 current smokers, and 8
patients with COPD by high-performance liquid chromatography. The level of oxidant
and antioxidant activity were quantified using derivatives of reactive oxygen metabolite
(d-ROM) and bio-antioxidant power (BAP). The result indicated that plasma acrolein
were significantly high in COPD patients’ smokers than non-COPD smokers confirming
heightened acrolein concentrations were highly implicated in the pathogenesis of COPD
through meddling in the balance of oxidative stress as against antioxidant potency.
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2.6 Epigenetics
Epigenetics is the change in phenotypic features of an individual without changing the
genotypic constituents of the individual that is liable for how cells read the genes. There
are different ways through which epigenetic adjustments can ensue. It either arise
naturally or can be determined by different reasons such as age, environmental exposure,
individuals’ lifestyle, and disease state. Epigenetic alteration happens in such a way that
the cell differentiates in a manner that results in liver cells, brain cells, and skin cells.
Dysfunctional epigenetic modification can result in disease conditions, an example is
cancer.
2.6.1 DNA Methylation
DNA Methylation is the most popular mechanism of epigenetic modification where a
methyl group (CH3) is attached to the segments of DNA. The attachment results in the
turning off the genes, silencing or inactivating it thereby inhibiting the production of
protein from the modified gene. It could also lead to abnormal gene transcription which is
the chief cause of genetic disorders such as cancer, cardiovascular and respiratory
diseases, metabolic and degenerative disorders. (Santos et al., 2007).
Methods of DNA methylation at cytosine residues, precisely at CpG sites, is a lively and
revocable epigenetic modification (Ramchandani et al., 1990). In human genome, clusters
of CpG sites regions are known as CpG Island that are normally found in closeness to or
within transcription start site (TSS) along with the promoters of housekeeping and/or
tissue-specific genes ( Gardiner et al., 1987). DNA Methyl transferase enzymes also
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known as DNMTs are group of enzymes that control the addition of methyl groups in
different levels in cells. There are three major types are of DNMTs, DNMT1 are the
methylation enzymes responsible for the maintenance of established patterns of DNA
methylation while DNMT3A and DNMT3B mediate establishment of new or de
novo DNA methylation patterns. Addition of a methyl group to cytosine at its fifth
carbon, creating 5-methylcytosine (5-mc), by the three major DNA methyltransferases
(DNMT1, DNMT3A, and DNMT3B) are implicated to be the basis of repression of
linked genes as this mark and about of transcription start site (TSS), has been associated
to transcriptionally repressed chromatin that rejects access for transcription factors, such
as serum response factor (SRF) (Jones, 2012).
DNA Methylation through DNMT1 has shown to play essential role in the development
of gastrointestinal smooth muscle cells of rats and diseases which is demonstrated in
study done by Brian G. Jorgensen et al., (2018), the study was done using DNMT1knockout mice and disease human GI tissue. The outcome validates that DNA
hypomethylation in embryonic smooth muscle cells (ESMC), via
congenital DNMT1 deficiency, contributes to massive dysregulation of gene expression
and is lethal to GI-SMC.
The outcomes also propose that DNMT1 has an essential role in the embryonic, primary
development process of SMC with consistent patterns being found in human GI diseased
tissue. Chromatin remodeling, histone modifications, and non-coding RNA are other
forms of epigenetic mechanism.
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Understanding genetic processes and how environmental factors affect the phenotypic
features of a gene became a concern which bring about clarification of Conrad
Waddington (1942) molecular basis of epigenetics. His observation unraveled how
environmental stress impacted on the physical features in Drosophila fruit flies. From
then on, research endeavor has paid attention to scrutinizing epigenetic mechanism in
relation to different epigenetic changes that have occurred and how it relates to human
disorders and disease conditions.
In 1969, Griffith and Mahler proposed that DNA methylation can be essential in longterm memory function (Holliday, 2006). A distinctive epigenetic point was identified
because of mild DNA methylation of insulin-like growth factor II (IGF2) gene (Heijmans
et al., 2008). Similarly, famine prenatally exposed adults were also recognized to have a
notable occurrence of schizophrenia (St Clair et al., 2005).
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Figure 2.2: Schematic Representation of DNA Methylation (Christina Ambrosi et al.,
2017).
Phenotypic changes that occur in individual adult life is because of prenatal and postnatal
environmental exposures interfering with epigenetic marks which control the information
that is stored in the genome. A study conducted by Waterland et al, (2003) reported that
administering a methyl donor supplement (vitamin B12, betaine choline, and folic acid)
to a woman during gestation period can affect the phenotype of the offspring (viable
yellow agouti) through direct alteration of the epigenome (Dolinoy et al., 2006). Studies
conducted using animal models has shown that short-term environmental exposure results
in prolonged alteration of epigenetic marks that have lasting phenotypic aftermath
(Sinclair et al., 2007; Waterland et al., 2003). Many researchers investigated embryonic
development because it is the essential stage of initiating and maintaining epigenetic
marks (Reik et al., 2001). In fact, culturing preimplantation of mice zygote shows that
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epigenetic marks are prone to a nutritional condition in the early period of life
development (Morgan et al., 2008; Doherty et al., 2000).
2.7 Ten Eleven Translocation (TET) Enzymes
TET enzymes are part of dioxygenases family known to be chiefly responsible for
oxidizing methylated cytosine. Research has shown important roles of TET enzymes in
various biological and pathological processes that ranges from regulation of DNA
demethylation, gene transcription, embryonic development, and oncogenesis (Xiaotong
Yin et., 2016). The three major member of this family are ten-eleven translocation methyl
cytosine dioxygenase 1 (TET1), methyl cytosine dioxygenase (TET2), and methyl
cytosine dioxygenase (TET3). TET 1 gene was initially acknowledged when it was
determined to be glued to the Mixed Lineage Leukemia (MLL) gene due to a
translocation event that happened between chromosomes ten and eleven henceforth the
name (Lorsbach RB et al., 2003).
The key role of these three forms of TET enzymes is their involvement in biochemical
pathway that converts 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC)
and subsequently regulates the conversion of 5hmC to 5-formylcytosine (5fC) and then
5fC to 5-carboxylcytosine (5caC). Even though experimental data shows that TET3 does
so to a lesser extent than TET1 and TET2. (He YF et al., 2011). Despite the fact that TET
enzymes were formerly believed to be foundation of DNA damage. Despite the fact that
TET enzymes were formerly believed to be foundation of DNA damage, Novel studies
have implied that this catalytic activity could essentially be the initial steps of DNA
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demethylation process. The demethylation process begins with the changing of 5-mC to
5caC after numerous rounds of oxidation by TET enzymes, followed by the elimination
of the modified cytosine base by thymine DNA glycosylase (TDG) which leaves an
abasic site on the DNA. Finally, base excision repair occurs where a new unmodified
cytosine is restored at the site, thus completing the process of DNA demethylation (Kohli
RM et al., 2013). Disturbance of epigenetic patterns as well as DNA methylation forms,
leads to the bedrock of cancer development. DNMT3A gene is an example of somatic
mutations in gene that codes for the machinery that bring about DNA methylation have
been causally connected to malignant transformation.
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One of the remarkable facts about TET enzymes is their involvement in the elimination
of epigenetic mark, which has appeared to be a vital mechanism in tumor cancer
suppression. It appears that the three TET genes are altered and demonstrate lessened
expression, and the proteins has decreased activity in a wide range of dissimilar cancer
types. Therefore, specific regulation of DNA methylation forms, which is somewhat
mediated by TET enzymes, is significant for typical growth and provides an ultimate
defense against cellular transformation (Kasper and Kristian, 2016).

Figure 2.3: Description of Cytosine’s Methylation and Demethylation processes.
Adjusted Forms of Cytosine Along with Resultant Enzymes Responsible for each
Modification by (What is epigenetics.com)
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2.8

DNA Demethylase

Demethylase enzymes has been discovered to catalyzes hydrolytic removal methyl
residue from methylated DNA. Research has also shown that DNA demethylase
completely removes methylated and hemi-methylated DNA revealing dinucleotide
specificity as well as elimination of mCpG sites in diverse sequence framework. It has
been reported that demethylase is a processive enzyme even though its limiting factor in
methyl residue elimination is the initiation of demethylation and is ascertained through
sequence characteristics. (Nadia et al., 1999).
A recent study Xirong Lu et al, 2020 explored the inhibition of NF-kB by oleanolic (OA)
acid to downregulate PD-L1 by promoting DNA demethylation in gastric cancer cells
focusing on epigenetic regulation using MKN-45 cells. MKN-45 cells were treated with
IL-1β (20 ng/mL) and/or OA at 30 and 40 µM for 24 hours. Measurements of DNA
demethylase activity was measured using 10 µg of nuclear protein extracts with the
EpiQuik DNA Demethylase Activity/Inhibition Assay kit. The findings demonstrated that
DNA demethylase activity showed high DNA demethylation states upon IL-1β exposure,
which was reversed by OA, implying an involvement of DNA methylation/demethylation
confirming that decreases DNA demethylation contributed to OA down regulation of PDL1 in IL-1β-treated gastric cancer.
2.9

N-Acetylcysteine

N- acetylcysteine (NAC) is an effective free radical scavenger known to stimulate the
production of endogenous glutathione. NAC is an optimal sulfhydryl group whose redox

20

state has demonstrated to be advantageous to human health by reason of its antioxidant
function to cells against damaging foreign bodies and other toxic pollutants. Nacetylcysteine is a derivative of amino acid residue L-cysteine. NAC is an antioxidant
that has been used extensively in therapy for several illnesses such as acetaminophen
poisoning, kidney and lung diseases, heart attack, stroke, epilepsy seizures, bipolar
disorder (Magalhaes et al., 2011 ; Briguori et al., 2002 ; Perry & Shannon, 1998 ; Bibi et
al., 1992). Studies has shown the usefulness of NAC in the abrogation of oxidative stress
induced by acrolein. NAC has shown to alleviate the biomarkers of oxidative stress in
cholestatic animal (Ali et al., 2019). In addition, NAC has been reported to prevent
acrolein-induced cytotoxicity via the enhancement of endogenous glatathione level
(Milton et al., 2015).
A research was carried out to investigate the effect of acrolein and chloro-acetaldehyde
(CAA) on human urothelial cells in vitro and to evaluate the effectiveness of NAC
against acrolein and CAA toxicity, the study used human urothelial cells (RT4 and T24)
the cells were treated with acrolein or CAA. The alterations in cell viability, reactive
oxygen species, caspase-3 were quantified. The result revealed that NAC significantly
protected the human urothelial cells against decrease cell viability, increased ROS
production induced by acrolein and CAA. (Kylie et al., 2019).
Another investigation was done to assess the role of NAC treatment on biomarkers of
oxidative stress and organ histopathological changes in a rat model of
cholestasis/cirrhosis. Bile duct ligation (BDL) animals were exposed to100 and 300
mg/kg of NAC through I.P for 42 days. oxidative stress biomarker in the liver, brain,
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heart, skeletal muscle, lung, serum, and kidney tissue, and organ histopathological
variations were examined. The data showed a substantial increase in reactive oxygen
species, lipid peroxidation, and protein carbonylation were identified in various tissues of
BDL rats. The study also revealed that tissue antioxidant capacity was impeded,
glutathione (GSH) reservoirs were reduced, and oxidized glutathione (GSSG) levels were
considerably enhanced in the BDL group. Substantial tissue histopathological changes
were apparent in cirrhotic animals. Addition of NAC substantially mitigated biomarkers
of oxidative stress and abrogate tissue histopathological alterations in cirrhotic rats.
These results demonstrated that NAC is a possible protective treatment for cirrhosis and
the subsequent obstructions (Mohammad et al., 2021).
Arwa Alnahdi et al., (2019) carried out an experiment to evaluate the molecular
mechanisms of oxidative stress, and inflammatory and antioxidant responses in the
presence of high concentrations of glucose and fatty acids aa well as quantify the effect
of N-acetyl cysteine protective ability on β-cell toxicity. An insulin-secreting pancreatic
β-cell line (Rin-5F) were used in the study. The data illustrated that the cellular and
molecular mechanisms underlying β-cell toxicity are caused by elevated oxidative stress,
imbalance of redox homeostasis, glutathione metabolism and changes in inflammatory
responses. Addition of NAC decreased oxidative stress and modifications in GSH
metabolism linked with β-cells cytotoxicity.
A 2020 review done by Zhongcheng, and Carlos stated that NAC could combat COVID19. NAC is identified for its anti-inflammatory and immune-modulating characteristics
and a powerful precursor for cellular glutathione which is known to protect the body
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system against harmful effect based on the pathway of toxicity. NF-kB activation is the
pathway for the replication of human coronaviruses (HCoV-229E). Since NAC is
recognized to suppress activation of NF-kB, this implies that administration of NAC
could reduce the replication rate of COVID 19 and as such reduced disease severity. In
addition, a cohort study done by (Ibrahim et al., 2020) showed that intravenous
administration (IV) of NAC considerably ameliorate disease conditions in 10 severe
respirator-dependent COVID-19 patients, aged from 38 to 71 years, including one with
Glucose-6-phosphate dehydrogenase (G6PD) deficiency. IV administration of NAC
decreased inflammatory markers, for example C-reactive protein (CRP) and ferritin, and
similarly enhanced lung functions. Eight out of ten patients were released, and the other
two patients displayed better condition before the study was published. Therefore,
concluded that this clinical practice additionally verifies the efficacy of NAC in COVID19 treatment.
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CHAPTER 3
MATERIALS AND METHOD
3.1 Ethical Aspect of Research
This study was approved by Texas Southern University Institutional Animal Care and
Use Committee (IACUC) and adhered to National Institutes of Health (NIH) guideline
and animal welfare act for handling laboratory animals. Male Sprague Dawley were used
for this study. There were no use of human or germ cells.
3.2 Materials
Male Sprague Dawley rats were purchased from ENVIGO (Indianapolis, United States),
Acrolein from Sigma-Aldrich Chemicals (St Louis, MO), BCA protein assay kit from
Pierce (Rockford, IL, USA), EpiQuik Nuclear Extraction Kit, EpiQuik DNMT
Activity/Inhibition Assay Ultra Kit, Epigenase 5mC-Hydroxylase TET
Activity/Inhibition Assay Kit, Epigenase Thymine DNA Glycosylase (TDG)
Activity/Inhibition Assay Kit, EpiQuik DNA Demethylase Activity/Inhibition Assay
Ultra Kit, EpiQuik 8-OHdG DNA Damage Quantification Direct Kit all from
EPIGENTEK (Epigentek Group Inc. 110 B County Blvd. Ste 122 Farmingdale, NY
11735 United States). 1 x Global DNA Methylation Assay Kit and Global DNA
Hydroxymethylation Assay Kit from ABCAM. Odyssey classic from Licor for
immunoblotting, Tissue-Lyser (Qiagen), Centrifuge (Eppendorf), and holding and
metabolic cages.
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3.3.1 Treatment
Male Sprague Dawley (300-400 g, ENVIGO) were treated with or without acrolein (2
mg/kg/day,7 days) and NAC (600 mg/kg/day, 10 days). The control group was subjected
to the same experimental protocol and received equal amount of vehicle. Animals were
weighed at the start of treatment, labeled, and put in holding cages. Urine samples were
also collected before and after treatment. Animals had free access to food and water
during the duration of treatment according to approved animal care protocols.
A total of 28 rats were divided into four groups. Group one was the control (wild Type)
which was treated for 7 days with 400 ul of phosphate buffer saline (PBS) and 3.7% of
DMSO via intraperitoneal injection (I.P). Second group was treated with acrolein (2
mg/kg/day for 7 days, via I.P). The third group was treated with 600 mg/kg/day of Nacetyl cysteine (NAC) via I.P for 10 days. The fourth group was treated with acrolein (2
mg/kg, 7 days, I.P) plus 600mg/kg/day of NAC for 10 days via I.P (400 µl) (Table 3.1).
Addition of acrolein treatment started after three days of treatment with NAC. All
treatment dilutions followed approved recommendation from manufacturer.
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Experimental Design
Table 3.1

Group
NO.

Group Name

Treatment
Concentration

1

Control

400µg PBS, 3.7%
DMSO

I.P

7

2

Acrolein

2mg/kg/day

I.P

7

7 Days

3

NAC

600mg/kg/day

I.P

7

10 Days

2mg/kg
+600mg/kg NAC

I.P

7

Ist 3 days NAC
only then 7
NAC +ACR

4

ACR + NAC

3.3.2

Route of
Exposure

Number of
Rats

Exposure
Duration

7 Days

Collection of Organs and Body Fluid

Before and at the end of the treatment period, animals were placed in metabolic cages for
24 hours for urine sample collection. Blood was collected in anesthetized rats and rats
were sacrificed at the end. Liver, heart, kidney, and aorta were harvested, rinsed, and
immediately frozen at -80 °C according to approved protocols. kidney tissue was used for
biochemical analysis.
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3.4

Lipid Peroxidation

Levels of lipid peroxidation was measured using ABCAM Lipid Peroxidation (MDA)
Assay Kit (Cambridge, MA) following manufacturers according to supplier’s protocol.
The kit directly measures malondialdehyde (MDA) the biomarker of lipid peroxidation.
50µl of kidney homogenate was used for the assay. The reagents were added to 96-well
plates. Plates were incubated for 60 minutes, and absorbance was read at 695nm per
supplier protocol.
3.5 Global DNA Methylation
Global DNA methylation was measured using abcam global DNA methylation Assay kit
(5 methyl cytosine) (Cambridge, MA) according to the manufacturer’s protocol. DNA
was isolated from Sprague-Dawley rats tissue using Qiagen AllPrep DNA/RNA/Protein
Mini Kit (Germantown, MD). DNA concentration was measured using Nanodrop One
Technology from Thermo Fisher Scientific (Carlsbad, CA). 100ng of purified DNA were
used to perform the ELISA assay. Absorbance was read at 450 nm on a microplate reader
(SpectraMax M2; Molecular Devices, Sunnyvale, CA, USA). Global DNA methylation
quantification was calculated as ng/percentage. Data are expressed in percentage
difference over unexposed (control) DNA lysates.
3.6

Global DNA Hydroxymethylation

Global DNA Hydroxymethylation was measured using abcam global DNA
Hydroxymethylation Assay kit (5hmc) (Cambridge, MA) according to the manufacturer’s
protocol. DNA was isolated from Sprague-Dawley rats tissue using Qiagen AllPrep
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DNA/RNA/Protein Mini Kit (Germantown, MD). DNA concentration was measured
using Nanodrop One Technology from Thermo Fisher Scientific (Carlsbad, CA). 100ng
of purified DNA were used to perform the ELISA assay. Absorbance was read at 450 nm
on a microplate reader (SpectraMax M2; Molecular Devices, Sunnyvale, CA, USA).
Global DNA Hydroxymethylation quantification was calculated as ng/percentage. Data
are expressed in percentage difference over unexposed (control) DNA lysates.
3.7 DNA Damage Quantification
DNA damage quantification was measured using EpiQuik 8-OHdG ( 8-hydroxy-2'deoxyguanosine) DNA Damage Quantification Direct Assay (Farmingdale, NY)
according to the manufacturer’s protocol. DNA was isolated from Sprague-Dawley rats
tissue using Qiagen AllPrep DNA/RNA/Protein Mini Kit (Germantown, MD). DNA
concentration was measured using Nanodrop One Technology from Thermo Fisher
Scientific (Carlsbad, CA). 100ng of purified DNA were used to perform the ELISA
assay. Absorbance was read at 450 and 655 nm on a microplate reader (SpectraMax M2;
Molecular Devices, Sunnyvale, CA, USA). DNA damage quantification was calculated
as ng/percentage. Data are expressed in percentage difference over unexposed (control)
DNA lysates.
3.8 DNMT Activity
DNMT activity was measured using the Epigentek EpiQuik DNMT Activity/inhibition
Assay Ultra kit (Colorimetric and Fluorometric method) (Farmingdale, NY) according to
the manufacturer’s protocol. Kidney tissue were used to extract nuclear protein, Nuclear
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lysates were prepared using Epigentek Nuclear Extraction kit (Farmingdale, NY) and
protein concentration was measured using the BCA assay from Thermo Fisher Scientific
(Carlsbad, CA). 10µg nuclear proteins were used to perform the ELISA assay.
Absorbance was read at 450 and 655 nm for Colorimetry and 530ex/ 590em nm for
Fluorometry on a microplate reader (SpectraMax M2; Molecular Devices, Sunnyvale,
CA, USA). DNMT activity was calculated as ng/min/mg. Data are expressed in
percentage difference over unexposed (control) nuclear lysates.
3.9 5-mC Hydroxylase TET Activity
Total TET activity was measured using the Epigentek Epigenase 5mC Hydroxylase kit
(Colorimetric and Fluorometric; Farmingdale, NY) according to the supplier’s protocol.
Kidney tissue were used to extract nuclear protein, Nuclear lysates were prepared using
Epigentek Nuclear Extraction kit (Farmingdale, NY) and protein concentration was
measured using the BCA assay from Thermo Fisher Scientific (Carlsbad, CA). 10µg
nuclear proteins were used to perform the ELISA assay. Absorbance was read at 450 and
655 nm for Colorimetry and 530ex/ 590em nm for Fluorometry on a microplate reader
(SpectraMax M2; Molecular Devices, Sunnyvale, CA, USA). Hydroxymethylated
product formed was measured within a standard curve (0–2 ng), TET activity was
calculated as ng/min/mg. Data are expressed in percentage difference over unexposed
(control) nuclear lysates.
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3.10 DNA Demethylase Activity
DNA Demethylase activity was measured using the Epigentek EpiQuik DNA
Demethylase Activity/inhibition Assay Ultra kit (Farmingdale, NY) according to the
manufacturer’s protocol. Extract nuclear protein, Nuclear lysates were prepared using
Epigentek Nuclear Extraction kit (Farmingdale, NY) and protein concentration was
measured using the BCA assay from Thermo Fisher Scientific (Carlsbad, CA).10µg
nuclear proteins were used to perform the ELISA assay. Absorbance was read at 450 and
655 nm on a microplate reader (SpectraMax M2; Molecular Devices, Sunnyvale, CA,
USA). DNA Demethylase activity was calculated as ng/min/mg. Data are expressed in
percentage difference over unexposed (control) nuclear lysates.
3.11 Thymine DNA Glycosylase Activity (TDG)
TDG activity was measured using Epigentek Epigenase TDG activity/inhibition assay kit.
(Farmingdale, NY) according to the manufacturer’s protocol. Kidney tissue were used to
extract nuclear protein, Nuclear lysates were prepared using Epigentek Nuclear
Extraction kit (Farmingdale, NY) and protein concentration was measured using the BCA
assay from Thermo Fisher Scientific (Carlsbad, CA).10µg nuclear proteins were used to
perform the ELISA assay. Absorbance was read at 450 and 655 nm on a microplate
reader (SpectraMax M2; Molecular Devices, Sunnyvale, CA, USA). TDG activity was
calculated as ng/min/mg. Data are expressed percentage difference over unexposed
(control) nuclear lysates.
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3.12 Statistical Analysis
Data are expressed as mean± SD from two or three independent experiments as indicated
in figure legends. t test and one-way analysis of variance (ANOVA) were used for
comparison of groups and between treatments for significant difference. Statistical
significance was ascertained by using Graph Pad Prism version 9.10 software from Graph
Pad Software, Inc. (La Jolla, CA, USA). P value ≤ 0.05 were considered significant.
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CHAPTER 4
RESULTS AND DISCUSSION

4.1

Changes in Animal Weight

In this study, 28 male Sprague Dawley rats were divided into four groups: control group,
NAC group (600mg/kg/day, 10 days), acrolein treated group (2mg/kg/day, 7 days), and
acrolein plus NAC group for the seven-day treatment. At the end of the treatment, there
were no significant difference in animals’ weight before and after treatment (Table 4.1).
4.2

Lipid Peroxidation

Malondialdehyde (MDA) is a biomarker for lipid peroxidation. To demonstrate that
acrolein induce toxicity in rats and show if NAC could reverse the toxicity, levels of lipid
peroxidation products were measured in rat kidney homogenate. Measurement of Lipid
peroxides indicated the group treated with acrolein had an approximately 169% increase
in MDA level when compared with the untreated control. The addition of NAC showed
an approximately 52% decrease in lipid peroxidation (MDA) level when compared with
the acrolein group (Figure 4.1).
4.3

Global DNA Methylation (5-mC) Assay

To measure the level of global 5-mC in acrolein-induced DNA methylation and disclose
whether NAC could hinder the effect of acrolein and thus, reverse DNA methylation. 5mC level was measured using Global DNA Methylation (5-mC) Assay kit. 100ng of
DNA sample from rat kidney tissue was used following the manufacturer’s protocol. The
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measurement of 5-mC level was done within the groups after treatment. The group
treated with acrolein indicated up to 15% increase in 5-mC level when compared with the
untreated control. The addition of NAC resulted in approximately 16% increase in 5-mC
level compared to acrolein group (Figure 4.2).
4.4

Global DNA Hydroxymethylation (5-HmC)

To measure the level of global 5-HmC in acrolein-induced DNA methylation and reveal
whether NAC could hinder the effect of acrolein and thus, reverse DNA methylation. 5HmC level was measured using Global DNA Hydroxymethylation (5-HmC) Assay kit.
100ng of DNA sample from rat kidney tissue was used following the manufacturer’s
protocol. The measurement of 5-HmC level was done within the groups after treatment.
The result revealed that group treated with acrolein indicated approximately up 22%
decrease in 5-HmC level compared to the untreated control. The addition of NAC
showed approximately 130% increase in 5-HmC level compared to the acrolein group
(figure 4.3).
4.5

DNA Damage Quantification

To quantify DNA damage in acrolein treated rats and whether NAC could thwart the
effect of acrolein we measured DNA damage. DNA damage quantification was measured
using EpiQuik 8-OHdG ( 8-hydroxy-2'-deoxyguanosine) DNA Damage Quantification
Direct Assay kit. 100 ng of DNA extracted from rat kidney tissue was used following the
manufacturer’s protocol. The measurement of DNA damage was done between the
groups at the end of the treatment. Results indicated approximately up to 18% decrease in
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8-OHdG level in rats treated with acrolein compared to the untreated control and to our
surprise addition of NAC further increased that by 167% when compared with the
acrolein group (Figure 4.4).
4.6

DNMT Activity

In this assay, we explored the role of DNMT enzyme in acrolein induced DNA
methylation and whether NAC could hinder the effect of acrolein. DNMT Activity was
measured using EpiQuik DNMT Activity/Inhibition Ultra Assay kit. 10µg nuclear extract
from rat kidney tissue was used following the manufacturer’s protocol. The measurement
of DNMT activity was done between the groups after treatment. The group treated with
acrolein resulted in 30% increase in DNMT activity when compared with the untreated
control and addition of NAC showed approximately 32% increase DNMT activity
compared to the acrolein group (Figure 4.5).
4.7

5-mC Hydroxylase TET Activity

In this study, we hypothesized that exposure to acrolein will affect DNA methylation and
interaction of acrolein with DNA methylation will contribute to acrolein-induced toxicity.
Therefore, in our study, we evaluated the role of TET enzymes in DNA
methylation/demethylation in differently treated groups of rats. 5mC Hydroxylase TET
Activity was measured using Epigenase 5mC Hydroxylase TET Activity/Inhibition
Assay kit. 10 µg nuclear extract from rat kidney tissue was used for the analysis
following the manufacturer’s protocol. Comparison of 5mC Hydroxylase TET activity
was done between the groups after treatment. We found out that tissue DNA methylation
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had a negative association with acrolein exposure. In other hands, the group treated with
acrolein indicated up to 33% decrease in 5mC Hydroxylase TET activity when compared
with the untreated control. Furthermore, we saw addition of NAC resulted in
approximately 28% increase in 5mC Hydroxylase TET activity compared with acrolein
group (Figure 4.6).
4.8

DNA Demethylase Activity

To evaluate the effect of acrolein and NAC on DNA demethylase, Demethylase activity
was measured using EpiQuik DNA Demethylase Activity/Inhibition Assay Ultra kit. 10
µg nuclear extract from rat kidney tissue was used following the manufacturer’s protocol.
The measurement of demethylase activity was done within the groups after treatment.
The results indicated an approximately 14% decrease in demethylase activity in the
acrolein-treated group compared to the untreated control. The addition of NAC showed
approximately 20% increase demethylase activity compared to the acrolein group (figure
4.7).
4.9

Thymine DNA Glycosylase Activity (TDG)

In this experiment, we wanted to assess the role of TDG enzyme in acrolein induced
DNA methylation/demethylation and to find out whether N-acetyl cysteine could avert
acrolein effect and impede DNA methylation. TDG activity were measured using
Epigenase Thymine DNA Glycosylase Activity/Inhibition Assay kit. 10µg nuclear
extract from rat kidney tissue was used following the manufacturer’s protocol. The
measurement of TDG activity was done within the groups after treatment. The result
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showed that group treated with acrolein indicated approximately 22% decrease in TDG
activity when compared with untreated control, the addition of NAC showed an
approximately 15% increase in TDG activity compared to the acrolein group (Figure 4.8).
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Changes in animal weight
Table 4.1 Mean animal body weight in grams (g) After 7 days Exposure

Group

1

Treatment/
Concentration

Weight before
Treatment

Weight after
Treatment

335.8±20.9

348±22.12

4%

NAC
(600mg/kg/day)

283±8.45

296±9.40

5%

ACR
(2mg/kg/day)

331±21.95

344±22.23

4%

388±8.28

399±8.50

3%

CON
(400µg 3.7%
DMSO)

Percentage
Difference

2

3

4

ACR+NAC
(2mg/kg+600mg/kg
NAC)
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Aim 1: To show acrolein induced toxicity in rat kidney tissue.
Figure 4.1 Effects of Acrolein/ NAC Treatment on Rat Kidney Tissue

Lipid Peroxidation (MDA) Assay

Absorbance @ 695nm

1.5

*

1.0

0.5

@

0.0
Con

NAC

ACR

ACR+NAC

Sprague Dawley rats were treated with 2mg/kg/day of acrolein in the presence or absence
of 600mg/kg/day of NAC. 50µl of Kidney tissue homogenate was used to measure lipid
peroxidation. Levels of lipid peroxides from control (Con) and acrolein (ACR) treated
rats with or without NAC for 7 days (acrolein and NAC group) and 3 days pretreated of
NAC following acrolein treatment for 7 days for ACR+NAC group. Values are expressed
as mean ±SEM. (error bars) *P≤ 0.05 compared to Con, @P≤ 0.05 compared to ACR.
Levels of lipid peroxidation activity showed significant (*P ≤ 0.0215 and @P ≤ 0.082 ).
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Aim 2: Demonstrate that acrolein induce toxicity in rats is through DNA methylation and
the resulting DNA damage, Assays carried out include:
Figure 4.2: Effects of Acrolein/ NAC Treatment on Global DNA Methylation 5-mC

Global DNA Methylation (5-mC) Assay

5-mC % @ 450 nm

15

@
10

*

5

0
CON

NAC

ACR

ACR+NAC

Sprague Dawley rats were treated with 2mg/kg/day of acrolein in the presence or absence
of 600mg/kg/day of NAC. 100ng of DNA sample from rat kidney tissue was used to
measure 5-mC level. Level from control (Con) and acrolein (ACR) treated rats with or
without NAC for 7 days (acrolein and NAC group) and 3 days pretreated of NAC
following acrolein treatment for 7 days for ACR+NAC group. Values are expressed as
mean ±SEM. (error bars) *P≤ 0.05 compared to Con, @P ≤ 0.05 compared to ACR. 5mC level showed significant (*P< 0.0001 and ns @P ≤0.0917).
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Figure 4.3: Effects of Acrolein/ NAC Treatment on Global Hydroxymethylation (5HmC)

Global Hydroxymethylation (5-HmC) Assay
0.06

5-HmC (%) @ 450 nm

@

0.05

0.04

0.03

*

0.02

0.01
CON

NAC

ACR

ACR+NAC

Sprague Dawley rats were treated with 2mg/kg/day of acrolein in the presence or
absence of 600mg/kg/day of NAC. 100ng of DNA sample from rat kidney tissue was
used to measure 5-HmC level. Level from control (Con) and acrolein (ACR) treated rats
with or without NAC for 7 days (acrolein and NAC group) and 3 days pretreated of NAC
following acrolein treatment for 7 days for ACR+NAC group. Values are expressed as
mean ±SEM. (error bars) *P ≤0.05 compared to Con, @P≤0.05 compared to ACR. 5HmC level showed significant (*P ≤ 0.0215 and @P ≤ 0.0082).
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Figure 4.4: Effects of Acrolein/ NAC Treatment on level of 8-OHdG

EpiQuik 8-OHdG DNA Damage Quantification
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Sprague Dawley rats were treated with 2mg/kg/day of acrolein in the presence or
absence of 600mg/kg/day of NAC. 100ng of DNA sample from rat kidney tissue was
used to measure 8-OHdG level. Level from control (Con) and acrolein (ACR) treated rats
with or without NAC for 7 days (acrolein and NAC group) and 3 days pretreated of NAC
following acrolein treatment for 7 days for ACR+NAC group. Values are expressed as
mean ±SEM. (error bars) *P ≤0.05 compared to Con, @P ≤ 0.05 compared to ACR. 8OHdG level showed significant (*P ≤ 0.0198 and @P ≤ 0.0016).
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Aim 3: Evaluate the activities of DNA methylation/demethylation enzymes. Assays
carried out include:
Figure 4.5: Effects of Acrolein/ NAC Treatment on DNMT Activity
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Sprague Dawley rats were treated with 2mg/kg/day of acrolein in the presence or
absence of 600mg/kg/day of NAC. Kidney tissue was used to extract nuclear protein
(10µg) for DNMT activity. Activity from control (Con) and acrolein (ACR) treated rats
with or without NAC for 7 days (acrolein and NAC group) and 3 days pretreated of NAC
following acrolein treatment for 7 days for ACR+NAC group. Values are expressed as
mean ±SEM. (error bars) *P≤ 0.05 compared to Con, @P ≤ 0.05 compared to ACR.
DNMT activity showed significant (*P ≤ 0.0074 and @P ≤ 0.0099).
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Figure 4.6: Effects of Acrolein/ NAC Treatment on TET Activity
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Sprague Dawley rats were treated with 2mg/kg/day of acrolein in the presence or absence
of 600mg/kg/day of NAC. Kidney tissue was used to extract nuclear protein (10µg) for
5mC Hydroxylase TET activity. Activity from control (Con) and acrolein (ACR) treated
rats with or without NAC for 7 days (acrolein and NAC group) and 3 days pretreated of
NAC following acrolein treatment for 7 days for ACR+NAC group. Values are expressed
as mean ±SEM. (error bars) * P ≤ 0.05 compared to Con, @P ≤ 0.05 compared to ACR.
5mC Hydroxylase TET activity showed significant (*P ≤ 0.0126 and @P ≤ 0.0055).
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Figure 4.7: Effects of Acrolein/ NAC Treatment on DNA Demethylase Activity
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Sprague Dawley rats were treated with 2mg/kg/day of acrolein in the presence or
absence of 600mg/kg/day of NAC. Kidney tissue was used to extract nuclear protein
(10µg) for demethylase activity. Activity from control (Con) and acrolein (ACR) treated
rats with or without NAC for 7 days (acrolein and NAC group) and 3 days pretreated of
NAC following acrolein treatment for 7 days for ACR+NAC group. Values are expressed
as mean ±SEM. (error bars) *P ≤ 0.05 compared to Con, @P ≤ 0.05 compared to ACR.
Demethylase activity showed significant (*P ≤ 0.0234 and

@

P ≤ 0.0190).
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Figure 4.8: Effects of Acrolein/ NAC Treatment on Thymine DNA Glycosylase
Activity
Epigenase Thymine DNA Glycosylase Activity
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Sprague Dawley rats were treated with 2mg/kg/day of acrolein in the presence or absence
of 600mg/kg/day of NAC. Kidney tissue was used to extract nuclear protein (10µg) for
demethylase activity. Activity from control (Con) and acrolein (ACR) treated rats with or
without NAC for 7 days (acrolein and NAC group) and 3 days pretreated of NAC
following acrolein treatment for 7 days for ACR+NAC group. Values are expressed as
mean ±SEM. (error bars) *P ≤ 0.05 compared to Con, @P ≤ 0.05 compared to ACR.
TDG activity showed significant (*P ≤ 0.0265 and ns @P ≤ 0.1149 ).
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4.10

DISCUSSION

The objective of this study was to examine acrolein-induced epigenetic modification of
DNA in rat kidney tissue. Humans exposure to several environmental pollutant acrolein,
a very toxic compound, can be via inhalation, dermal contact, ingestion, and
endogenously production of the compound in the body through lipid peroxidation
process. Elevated level of acrolein in the body system has been indicated in variety of
diseases such as neurological, inflammatory, and cardiovascular diseases, cancer etc.
(Akshata et al., 2015). N-acetyl cysteine (NAC), through its antioxidant activity, can be a
god candidate to inhibit acrolein toxicity and the subsequent deleterious effects.
The significance of DNA methylation is stressed by the increasing number of human
diseases that are known to take place when DNA methylation is improperly recognized
and/or sustained. Abnormal DNA methylation linked to amplified expression or the
activity of DNMTs has been found in several diseases, particularly in cancer, in
cardiovascular and respiratory diseases, metabolic and degenerative disorders. Inhibition
of DNMTs may lead to demethylation and expression of silenced genes as well as a
therapeutic solution (Santos et al., 2007).
Our previous studies with VSMC has shown acrolein capability to modify histones H3
which is known to play vital role in gene expression and transcription (unpublished data).
Furthermore, we observed that NAC has the ability to inhibit acrolein toxicity and the
subsequent deleterious effect through prevention of histones H3 modification. The goal
of the current study was to ascertain if acrolein induced toxicity was via DNA
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methylation, and changes of methylation and demethylation enzymes. Rat models treated
with 2mg/kg/day of acrolein for seven days in the presence and absence of 600mg/kg/day
per body weight of NAC for 10 days were used to test our hypothesis.
4.11.1

Changes in animal weight

Treatment of rats with subtoxic level of acrolein for seven days did not result in any
significant changes in the animal weight at the end of this study (Table 4.1).
4.11.2

Effect of Acrolein in Lipid Peroxidation

Many investigations have shown that free radicals are the major cause of oxidative stress.
Increased oxidative stress contributes to lipid peroxidation. Lipid peroxidation is the
process of oxidative degradation of lipids by free radicals which removes electrons from
critical lipids in the cell membranes. At the end of the process, reactive aldehydes such as
malondialdehyde and 4-hydroxynonenal are produced that can be measured for
determination of changes in lipid peroxidation (Ron Shah et al., 2021). The aldehydes
produced at the end of lipid peroxidation have reported to be important signaling
intermediates in regulating important transcription factors and ultimately, resulting in
modification of physiological functions (Baliga et al., 2013).
Lipid peroxidation has been implicated in different disease conditions such as cancer,
atherosclerosis, acute lung injury, chronic alcohol exposure (Jie Wang, et al., 2021,
Thiago C, et al., 2021). Our previous study with Vascular Smooth Muscle cells has
shown that acrolein induced lipid peroxidation (Unpublished data) through the generation
of free radical. To confirm that acrolein induces toxicity is via lipid peroxidation in rats
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and to show whether NAC could reverse the toxicity, we measured level of lipid
peroxidation in rats exposed to acrolein with or without NAC. Levels of lipid
peroxidation products were measured in rat kidney tissue homogenate using ABCAM
Lipid Peroxidation (MDA) Assay Kit. The result showed that lipid peroxidation level was
increased by approximately 169% in acrolein treated rats compared with untreated group
(Figure 4.1). Addition of NAC reduced lipid peroxidation by approximately 52% when
compared with acrolein group. The increased in lipid peroxidation in acrolein treated
group can be explained by the fact that acrolein contributes to increased level of free
radicals as well as itself acting as a free radical and ultimately damaging polyunsaturated
lipids in the cell membrane. Additionally, increased in free radical generation can damage
endogenous antioxidant system resulting in depletion of the cellular antioxidant. Our data
also showed that NAC impedes acrolein effect which may be through the enhancement of
cellular antioxidant. Our results also agree with (Zahid Lepara et al., 2020) who carried
out a study on serum MDA levels as a potential biomarker of cancer progression for
patients with bladder cancer. The study included 90 patients among whom are tobacco
smokers. Serum MDA level revealed a significantly increased in the distribution of
tobacco smoker patients by 53.3% compared to 46% of control group (non-smokers).
They concluded that MDA serum level might play a significant role as a biomarker in the
diagnosis of bladder cancer.
In addition, research has laid emphasis on the importance of oxidative stress outcomes in
cancer development and the function of antioxidants in the prevention and treatment
(Valko M. et al., 2004).
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4.11.3

Global DNA Methylation (5-mC)

DNA methylation is the most broadly studied epigenetic alteration where a methyl group
is affixed to the segments of DNA. This fixing may result in either turn off of gene,
suppress or inactivation by means of hindering the production of proteins from the altered
gene. The outcome of modifications might result in an unusual gene transcription and
expression which is known to cause genetic disorders, such as metabolic and
degenerative disorders, cardiovascular and respiratory diseases, and cancer (Santos et al.,
2007). The significance of 5-mC as an important epigenetic modulation in phenotype as
well as gene expression has been acknowledged extensively. Some studies have reported
that, a decrease in global 5-mC i.e., DNA Hypomethylation is probable instigated by
methyl deficiency owing to a variety of environmental influences (e.g., acrolein) and has
been projected as a molecular marker in numerous biological methods such as cancer
(what is Epigenetics., 2021). Exposure to air pollutants has been reported to contribute to
development of cardiovascular diseases. It has been hypothesized that these exposures
contribute to changes in gene expression either directly or indirectly. For this reason,
studying epigenetic changes has become an area of interest to explain some of the
epigenetic modifications. To understand whether exposure to acrolein affects DNA, we
measured global DNA methylation in the present or absence of NAC. Our result (Figure
4.2) demonstrated about 16% increase in 5-mC level in acrolein treated group when
compared with untreated control. This could indicate acrolein has the capacity to induce
toxicity via hypomethylation which agrees with Melanie Ehrlich et al., (2009) reporting
that DNA hypomethylation was the initial epigenetic abnormality known in human tumor
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development. Similarly, another study reported DNA methylation patterns vary
significantly following smoke exposure and during exacerbations caused by bacterial
infections in COPD progression. This group utilized in vitro models that mimics COPD
and assessed the role of NF-kB and STAT3 methylation promoter. Human A549 cells
were exposed to cigarette smoke extract (CSE) for 3 hours and also 3-hour exposure with
a bacterial lipopolysaccharide prior to termination to CSE exposure. The results showed a
significance hypomethylation of NF-kB mediated pathway genes linking it with their
initiation of COPD exacerbation in study CSE model (Gagandeep Kaur et al., 2020).
Addition of NAC resulted in about 16% increase in 5-mC level when compared to
acrolein group. In addition, a study by Kanidta Sooklert et al., (2019) also revealed that
NAC reverses the decrease in methylation status caused by engineered cold, silicon, and
chitosan nano particles. Human embryonic kidney and human keratinocyte (HaCaT) cells
were exposed to three separate types of ENPs: gold nanoparticles, silicon nanoparticles
(SiNPs), and chitosan nanoparticles (CSNPs). The results indicated that the HaCaT cells
exposed to SiNPs exhibited increased ROS levels, whereas HaCaT cells that were
exposed to SiNPs and CSNPs experienced global as well as Alu hypomethylation, with
no change in LINE-1 being observed in none of the cell line. The demethylation of Alu in
HaCaT cells following exposure to SiNPs and CSNPs was inhibited when the cells were
pretreated with NAC.
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4.11.4 Global Hydroxymethylation (5-HmC)
Several investigators have confirmed the role of DNA methylation and
hydroxymethylation as potential players in body response to air pollutants. 5Hydroxymethyl cytosine is the product of TET oxidative breakdown of 5- methyl
cytosine in the demethylation process. The biological importance of 5-hmC as an
essential epigenetic variation in phenotype and gene expression has been recently
identified. For instance, global decrease in 5-hmC level (DNA hypohydroxymethylation)
has been displayed in just about all cancers and has been projected as a molecular marker
and curative target in cancer ( Gerd P Pfeifer et al., 2013). In the present study, to better
understand the effects of environmental exposures to acrolein and the roles of epigenetic
mechanism in acrolein-induced toxicity, we measure the level of global 5-HmC in rats
treated with acrolein in the presence or absence of NAC. The collected data indicated up
to about 22% decrease in 5-HmC level when compared with control (figure 4.3). Both
markers of DNA methylation, 5-mC and 5-HmC, are products of DNMTs and TET
enzyme activities respectively, have opposite functions. While 5-mC has been reported to
result in suppression of gene expression, 5-HmC has been reported to cause activation
and /or maintenance of gene expression. For that reason, in any epigenetic study, it is
important to measure level of both these products to have a better understanding of
epigenetic changes (Summary of results from Geneva World Health Organization burden
of disease from ambient Air pollution for 2014). Swati Kadam et al., (2013) have also
reported an association between carcinogenesis and loss of global 5hmC. In the same
manner, a liquid chromatography-mass spectrometry, anti-5hmC antibody-based
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immuno-dot blots and immunohistochemistry investigation has exhibited tumor-linked
with global loss of 5hmC in cancers of the lung, brain, breast, liver, kidney, prostate,
intestine, uterus, and melanoma (Jin SG et al., 2011). In our study, addition of NAC
resulted in approximately 130% increase in 5-HmC level when compared with acrolein
group, indicating NAC beneficial effects might be through upregulating 5-HmC activity.
4.11.5

DNA Damage Quantification

Oxidative stress is one of the common mechanisms proposed for acrolein-induced
toxicity (Moghete et al., 2015). 8-OHdG, a sensitive biomarker of oxidative DNA
damage is produced from hydroxyl radicals generated from the derivative of
deoxyguanosine. Numerous studies have implicated 8-OHdG to be vital not only due to
its abundance but its mutagenic potential via G- transversion upon duplication of DNA.
8-OHdG is known to play a significance role in epigenetic regulation of gene
initiation/suppression by constraining the binding affinity of MBD protein to the CpG site
of DNA. Also, 8-OHdG is a crucial marker for measurement of oxidative DNA damage
in humans after exposure to cancer agents such as tobacco smoke, asbestos fibers, heavy
metals, and polycyclic aromatic hydrocarbon as well as risk factor for many diseases
wherein cancer is included (Athanasios et al., 2009).
Various investigators have reported changes in the level of 8-OHdG is linked to the
prognosis of cancer but the precise biomarker for diagnosis of human cancer is still
unclear (Xiangcheng Qing et al., 2019). Biological studies have to consider exposure
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level and analytical methods of measuring 8-OHdG when drawing conclusion as it could
present an inconsistent effect (Sajous et al., 2008).
In the present study, we wanted to assess the relation between exposure to acrolein and
the occurrence of DNA damage by measuring biomarkers effect, 8-OHdG. Furthermore,
we were interested to see if addition of NAC can prevent the damage. The results (Figure
4.4) showed that the group treated with acrolein had approximately 18% decrease in 8OHdG level when compared with untreated control. This could be interpreted as acrolein
inducing DNA damage through oxidative stress. Our results are in agreement with Deyao
et al., (2019) that low 8-OHdG expression is related with the prognosis of cancer. The
addition of NAC showed about 167% increase in 8-OHdG level when compared with
acrolein group which could indicate the ability of NAC to hinder the induced toxicity
caused by acrolein and reversing DNA damage (Sooklert et al., 2019).
4.11.6

DNA Methyltransferase Enzyme (DNMT) Activity

DNA Methyl transferase enzymes also known as DNMTs are group of enzymes that
control the addition of methyl groups from S-adenosyl- L-methionine (SAM) to the fifth
carbon position of cytosine rich CpG island of the DNA. The aberrant methyl group
addition by DNMTs is the sole cause of DNA methylation (de novo or maintenance)
which has been associated to different abnormal DNA function that results in the
epigenetic modification of gene transcription and expression. Consequently, these
modifications have been shown in different studies to be the onset of various chronic
diseases such as different types of cancer and cardiovascular disease. (Jiayu Zhang et al.,
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2020). Studies has also stated that unusual DNMT activities impinge on tumor-related
factors for instance genomic instability plus hypermethylated suppressor which increase
the growth of tumors, exacerbate the diagnosis for patients, and greatly escalate the
complexity of cancer treatment. (Cheng Yang et al., 2020). To further, elucidate the
mechanism of epigenetic changes in rats exposed to acrolein, we investigated changes in
DNMT enzymes and whether NAC could hinder the effect of acrolein and thus, reversing
DNA methylation. Our observation (Figure 4.5) showed that rats treated with acrolein
expressed a 30% increase in DNMT activity when compared with untreated control.
Addition of NAC further increased DNMT activity by 32%. The activity of DNMT is
highly regulated. It has been reported that interactions with different molecules, post
translational modifications, alternative silencing and gene duplication or gene loss are the
main regulatory mechanisms of DNMT activity. Considering the high activity of acrolein
and its action in inducing generation of free radicals, it is not surprising to see the
observed changes in our study. Mutation of DNMT has been reported in association of
several diseases, including several cancers. It is possible that acrolein is affecting the
balance between changes that contribute to higher DNA methylation and removal of the
methyl group. It is possible that modification of expression of enzymes such as DNMT
and TET as well as contribution of oxidation is leading to global hypomethylation by
acrolein and the consequence toxicity. This observation agrees with a study done by
Pankaj et al., (2014) disclosing the DNMT activity and the role of N-methyl-D-aspartate
receptor-1 (NMDAR1) in epigenetic mechanisms of heart failure, using cardiomyocytes
during hyperhomocysteinemia (HHcy) utilizing HL-Cells treated with 4 different
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concentrations of Hcy. The result showed that the group with high level of Hcy showed
an increase in DNMT activity which echoed a global methylation. Although we were
anticipating a decrease in DNMT activity upon addition of NAC, to our surprise, this
group showed further increase in DNMT activity. Furthermore, investigation will be
conducted to better understand the observation.
4.11.7

5mC Hydroxylase TET Activity

Cytosine methylation and consequent oxidation process has been the bedrock of
epigenetic modification in human and animal genomes. 5mC is a natural cytosine
nucleotide around the DNA which has been modified through the addition of methyl
group at the fifth carbon. This addition is very important, it has been believed that 5mC is
the DNA fifth base. 5mC plays a crucial role in transcription process as a gene repressor.
In promoters, 5mC is linked to steady, long-term transcriptional silencer. This could
happen either through opposing positive transcription factors or by enhancing the
attachment of negative ones. The aberrations have mainly been indicated in diverse
prognosis of diseases which cancer development is one of them. Ten eleven translocation
enzymes have been discovered to be the bridge between 5-mC methylation and
demethylation through the oxidative breakdown of 5-methyl cytosine to 5hydroxycytosine and further regulates the conversion of 5hmC to 5-formylcytosine(5fC)
and then 5fC to 5-carboxylcytosine (5caC) forming the basis of cytosine methylation
reversal. It also play a vital role in regulating epigenetic alterations (Jungeun An et al.,
2017).
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Research has shown that genomic 5-HmC levels correlate with TET hydroxylase activity.
In this study, we evaluated the effect of acrolein on the role of TET enzymes in DNA
methylation/demethylation and the effect of NAC on this process. 5-mC Hydroxylase
TET Activity was measured with kidney tissue from different groups for measurement of
total activity/inhibition of cytosine oxygenase TET enzymes in nuclear extracts. Results
indicated that the treatment of rats with acrolein resulted in approximately 67% decrease
in 5mC Hydroxylase TET activity when compared with untreated control. Addition of
NAC resulted in approximately 28% increase in 5mC Hydroxylase TET activity (Figure
4.6). TET loss of function has been reported in various cancers and restoration of TET
expression and /or function has been suggested as a possible approach for reversing the
clinical impact in those situations. Our results correlate with the effectiveness of TET
enzymes in DNA demethylation process reported by Kasper and Kristian (2016). It also
agrees with Xirong Lu et al., (2020) who carried a study to show the potency of TET3 in
the inhibition of programmed cell death protein 1 (PD-1) affected by oleanolic acid (OA)
promoting DNA methylation in gastric cancer cells (MKN-45). The result showed a
reduced expression of IL-1β-treated MKN-45 cells enhanced with OA and
overexpression of TET3 restored OA-reduced PD-L1 expression.
Aberrant DNA methylation has been reported in different cancer types (Bhusari et al.,
2011) as well as autoimmune diseases, metabolic disorders, neurological disorders, and
aging (Zelin Jin and Yun Liu., 2018). As an ubiquitous environmental pollutant as well as
the high activity of acrolein and functioning like a free radical, it is not surprising to see
observed effect by acrolein on 5mc Hydroxylase TET enzyme. There are reports of
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studies reporting low methylation in asthmatic children (Somineni et al., 2016). We are
suggesting that oxidative stress associated with exposure to acrolein has contributed to
the modification of TET enzymes expression which ultimately affects 5-HmC level.
Other investigators have also reported that exposure to toxicant in cigarette smoke
(benzene and benzene metabolites) contributes to global increase in 5HmC levels and
TET1 activity (Coulter et al., 2013) and have suggested that TET1 plays a vital role in
responding to pollutants (Bollati et al., 2007).
4.11.8

DNA Demethylase Activity

DNA demethylases are enzymes that eliminate methyl groups from DNA, proteins
(especially histones) and other cellular molecules. DNA demethylase enzymes are vital in
epigenetic modulation mechanisms. Demethylases modify transcriptional regulation of
the genome by regulating the methylation levels that takes place in DNA and histones
and therefore, control chromatin structure at specific gene sites within the organisms.
Biological importance of DNA demethylases is its effective mediation in DNA
demethylation which is an essential epigenetic process involved in maintaining normal
gene expression. (Weiwen et al., 2020). To further evaluate the underlying mechanism of
epigenetic changes in acrolein treated rats, we measured DNA demethylase activity. Our
results indicated that exposure to acrolein resulted in about 14% decrease in demethylase
activity when compared to control group. Addition of NAC prevented the effect of
acrolein on DNA demethylase activity (Figure 4.8). Our findings is suggesting that
increased oxidative stress as the result of exposure to acrolein is resulting in an imbalance
between DNA methylation and demethylation through effecting enzymes such as DNA
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demethylase. Imbalance of DNA methylation and demethylation have been reported to be
linked to pathological conditions such as cancer, asthma, and diabetes (Ji H et al., 2016;
Zhang X et al., 2017; Spearman et al., 2018).
Ryu et al., (2019) have reported that exposure to environmental pollutant PM 2.5,
resulted in a decrease in DNA methyltransferase (DNMT) expression and an increase in
DNA demethylase expression, and ultimately causing hypomethylation of p16INK4A
promoter region.
4.11.9

Thymine DNA Glycosylase Activity (TDG)

The significance of Thymine DNA glycosylase in DNA demethylation, repair, and
regulation of gene transcription has been established. TDG is known to participate in the
demethylation process of 5- methyl cytosine after numerous oxidations by TET enzymes.
TDG converts the 5-carboxyl cytosine to abasic cytosine that is next repaired to the
original status by base excision repair (Kohli RM et al., 2013; Charles E et al., 2021). In
this experiment, we wanted to assess the effect of acrolein on TDG enzyme in rats and
the consequence epigenetic changes. Our results showed that there was an approximately
22% decrease in TDG activity in the group treated with acrolein when compared with
untreated control and addition of NAC contributed to approximately about 15% increase
in TDG activity (Figure 4.9). This result indicates acrolein prevents demethylation
function of TDG and ultimately inducing methylation. These findings suggest that TDG
plays critical role in prevention of toxic effect of environmental pollutants by preventing
epigenetic modifications caused by these pollutants functions specific to cancer cells that
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make it highly suitable anti-melanoma drug test (Pietro et al., 2019; Mancuso et al.,
2019).
This result also acceded with an examination of TDG in reversing chromatin
condensation DNA repair and demethylation. This was done by assembling 12-mer
nucleosome arrays containing fluorescent donor and acceptor dyes that were placed at
locations that enables nucleosome stacking interactions, and the complete compaction of
the array specifically, the formation of 30 nm chromatin fibers, which was checked by
FRET (Forster resonance energy transfer). 2 mM of magnesium ion was added to
compact the nucleosome arrays. Addition of 200nM of TDG, reduced Fret efficiency by
approximately 20% suggesting that TDG caused decompaction of the nucleosome arrays
(Deckard et al., 2021) they confirmed their result by observed TF FOXA1, which is
recognized to actively introduce chromatin decompaction and boost DNA accessibility
(Cirillo et al., 2002). This shows that TDG have vital biological duty since its
involvement in DNA demethylation, chromatin remodeling, and transcriptional control.
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CHAPTER 5
SUMMARY, CONCLUSION AND RECOMMENDATION
5.1

Summary

Exposure to environmental pollutants have been reported to contribute and/ or exacerbate
disease conditions, which makes it important to understand the mechanism of toxicity of
individual pollutants. Acrolein is a common environmental pollutant that humans are
exposed to through a variety of ways. In the present study, we investigated epigenetic
changes in rats exposed to sub-lethal dose of acrolein in the presence or absence of NAC,
a natural antioxidant. Exposure of animals to a sub-toxic dose of acrolein 2mg/kg/day for
a short period of time (7 days) did not cause any apparent physiological change. As a
result, there was no significant difference between the weight changes of animals in
treated groups compared to the control.
It is well understood that changes at molecular and cellular level way exceed the time of
the apparent physiological damage. Therefore, in this study, our goal was to establish
epigenetic changes as a result of exposure to acrolein and the possible mechanisms
involved at low dose exposure of acrolein.
In the present study, we are reporting high level of lipid peroxidation in acrolein-treated
rats, which was alleviated after the addition of NAC. Furthermore, measurement of
global methylation indicated a 16% increase in 5-mC level in acrolein treated group
compared with control group. Generation of free radicals have reported to contribute to
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epigenetic changes and inflammation in different diseases. Increased free radicals can
affect gene expression through influencing epigenetic mechanisms such as DNA and
Histone Methylation. This can be the result of destruction of S-adenosyl methionine
which is important in the control of gene expression by DNA and histone
methyltransferases. Glutathione (GSH) which has been reported to be diminished as a
result of high generation of free radical species, might be an intermediate player in this
process. Additionally, we attempted to shade lights on the possible mechanisms that are
contributing to epigenetic changes in acrolein treated rats. We investigated changes in
methylation /demethylation enzymes, reporting a decrease in TET enzymes in acrolein
treated group and a significant increase after addition of NAC (Figures 4.4 and 4.5). The
result highlights TET enzymes as the bridge between 5-mC methylation and
demethylation through the oxidative breakdown of 5-methyl cytosine to 5carboxylcytosine (5caC) forming the basis of cytosine methylation reversal as well as
play a vital role in regulating epigenetic alterations. Furthermore, the steady reduction
was observed in activity of the demethylation enzyme DNA demethylase (Figure 4.6)
which is consistent with acrolein exerting toxicity and initiation of DNA methylation as
well as the potency of NAC antioxidant function. The same effect was seen in Thymine
DNA Glycosylase activity (Figure 4.5).
The present study also demonstrated that acrolein induced DNA methylation by altering
the activity of DNA methyltransferase (Figure 4.6) which is the enzyme responsible for
the addition of methyl group to the fifth carbon atom of cytosine in the CpG island of
DNA. This addition has been associated with different abnormal DNA function that
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results in the epigenetic modification of gene transcription and expression. The result
revealed a significant increase in DNMT activity when compared to untreated control
group agreeing with the goal of the study of acrolein induced toxicity via DNA
methylation. Furthermore, we evaluated level of global 5-HmC in rats treated with
acrolein in the presence or absence of NAC. The collected data indicated a significant
decrease in 5-HmC level when compared with control group.
Both markers of DNA methylation, 5mC and 5Hmc, are products of DNMTs and TET
enzyme activities but they have opposite functions. While 5mC has been reported to
result in suppression of gene expression, 5Hmc has been reported to cause activation
and/or maintenance of gene expression.
In our study, we observed a significance decrease in 5HmC level in acrolein-treated rats.
Similar reduction of 5HmC level has been reported in just about all types of cancers and
has been projected as a molecular marker and curative target in cancer. Finally, we
quantified DNA damage due to acrolein toxicity by measuring 8-OHdG level (the
oxidative biomarker for DNA damage) (figure 4.9). We observed a decrease in 8-OHdG
in acrolein group compared to untreated control which could indicate acrolein inducing
DNA damage through oxidative stress.

62

5.2

Conclusion

Based on the present data, we are concluding that epigenetic changes observed in
acrolein-treated rats are the results of increased generation of ROS, which contribute to
increase oxidation level, alteration of TET enzymes and their products, and increased
DNA methylation and subsequent DNA damage.
There are important implications of our findings. Our data suggest that acrolein exposure
may have great effect on triggering epigenetic changes by targeting key regulating
enzymes and thus leading to the development of inflammation. Furthermore, we are
proposing that addition of NAC can be an important approach in preventing/reducing the
toxic effect of acrolein.
5.3

Recommendation

Interleukins are involved in the initiation of pro-inflammatory responses in the body
during invasion of toxins or injury state. ROS have been reported to affect proinflammatory cytokines such as TNF-a, IL-1 and IL-8 which are critical in inflammatory
responses. Since acrolein contribute to increased changes in ROS and itself acts like a
free radical, we recommend more investigation to be carried out to investigate the link
between changes in TNF-a, IL-1 and IL-8 and epigenetic changes in acrolein-induced
toxicity. Furthermore, investigating individual members of TET enzyme family and
DNMTs and their various connection with acrolein is important. Finally, Further
confirmation of presented data using different methods can also add valuable information
in the confirmation of these results.
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APPENDIX
Future Studies
Based on the data obtained from this study and the observed effects on changes in the
activity of important enzymes involved in epigenetic modification, it is important to
confirm/link changes in the expression of proteins of these enzymes and their activity.
Therefore, we will perform western blot analysis to evaluate the effect of acrolein/NAC
on methylation and demethylation enzymes (TET1, DNMT 1, and DNMT3A) protein
expressions and check if it correlates with the enzyme activities that we have already
reported. The expression of these proteins will confirm obtained data and enable us to
make a better conclusion on changes found in epigenetic enzymes due to acrolein
treatment. We will also confirm NAC antioxidant function on reversing or reducing
acrolein induced DNA methylation through changes in demethylation enzymes.
The analysis will be carried out using the following procedure:
An average of 100g of the kidney tissue from each group was homogenized in RIPA
lyses buffer (Santa Cruz Biotechnology) and protease inhibitor cocktail (HALT; Thermo
Scientific) using a Tissue- Lyser (Qiagen). Homogenates will be centrifuged at 4°C at
1200 rpm for 20 minutes. The supernatants will be collected and used for the biochemical
analysis. Protein concentrations will be determined using BCA protein Assay kit and
reading was taken at 562nm. A total of 30μl of protein from kidney homogenate will
electrophoresed on 8% polyacrylamide gels. After two hours of electrophoresis (@ 50v
first and then @ 150v), gels will be transferred overnight to PVDF membrane (Bio-Rad
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Laboratories Inc. CA) @ 25v x 25max 100w. Blots (Membranes) will be probed
(incubated) overnight with corresponding primary antibodies.
For DNMT1 antibody dilution was at 1:500 dilution, (Epigentek), DNMT3A at 1:500
dilutions, (Epigentek),), and TET1antibody at 1:1000 dilution (Epigentek), After primary
incubation and washing off of primary antibody, respective secondary antibodies (HRPGoat Anti-Rabbit lgG and anti-Mouse) will be added to membranes at 1:10000 dilutions
and incubated for one hour. After incubation and washing, Odyssey Substrate detection
system from Licor (Lincoln, NE) with enhanced infrared fluorescence will be used to
visualize Immuno-complexes. The intensity of the bands will be scanned and quantified
using Odyssey Classic Scanner (Lincoln, NE). Buffer for 30 minutes and probed with
GAPDH antibody (1:5000) as house-keeping protein and also scanned for protein
expression. Quantitative measurements will be performed with GraphPad Prism 5
software.
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